Form 4 Tracker
Opus Genetics, Inc.
IRD

35 insider filings · Latest: Sep 30, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 23, 2026Apr 23 8:36 PMMagrath George
Proposed Sale
9,511$13.39$127.3K—

View →

Apr 23, 2026Apr 23 8:08 PMGagnon Robert E.
Proposed Sale
7,842$5.18$40.7K—

View →

Apr 23, 2026Apr 23 7:49 PMJayagopal Ashwath
Proposed Sale
7,542$5.19$39.2K—

View →

Mar 16, 2026Mar 18 8:12 PMJoseph K SchachleChief Operating Officer
Sale
3,719$5.25$19.5K300,781(D)

View →

Mar 16, 2026Mar 18 8:11 PMRabourn Amy ZarembaHead of Fin. Quality Assurance
Sale
2,816$5.25$14.8K190,312(D)

View →

Mar 16, 2026Mar 18 8:10 PMGeorge MagrathDirector, Chief Executive Officer
Sale
24,438$5.21$127.3K1,750,855(D)

View →

Mar 16, 2026Mar 18 8:09 PMAshwath JayagopalChief Scientific & Dev. Ofc.
Sale
3,719$5.12$19.0K516,775(D)

View →

Mar 16, 2026Mar 16 8:54 PMMagrath George
Proposed Sale
24,438$5.21$127.3K—

View →

Dec 29, 2025Dec 31 9:33 PMCam GallagherDirector
Purchase
164,000$1.97$323.7K83,000(I)

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 9, 2026Sep 11 8:09 PMGeorge MagrathDirector, Chief Executive Officer
Option Exercise
392,157$1.150(D)

View →

Sep 8, 2026Sep 8 8:05 PMCam GallagherDirector
Option Exercise
784,314$1.150(D)

View →